Purpose

This is a two-arm, prospective, longitudinal, randomized controlled trial (RCT) that will compare usual care to usual care plus a prenatally initiated, virtually administered psychological intervention, called HeartGPS.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Pregnant individual carrying a fetus diagnosed with CHD or biological mother of an infant diagnosed with CHD in the neonatal period. 2. Fetus or newborn with CHD anticipated to require cardiac surgery or transcatheter intervention in the first 30 days of life. 3. CHD diagnosis received between 16.0 and 30.0 weeks gestation. 4. Singleton pregnancy. 5. Pregnant mother is planning to continue the pregnancy and pursue surgical or transcatheter intervention for the infant. 5. Pregnant mother is able to participate and complete study assessments in English or Spanish.

Exclusion Criteria

  1. Mother, fetal, or infant medical condition determined by a treating clinician to be contraindicative to study participation. 2. Mother with a severe, untreated psychiatric condition, substance use disorder, or other circumstances that, in the opinion of the investigator, would interfere with engagement with study tasks or safe participation in the trial. 3. Mother with a moderate to severe intellectual disability or is otherwise unable to provide informed consent. 4. Postnatal diagnosis of CHD. 5. Fetus with a comorbid condition with a predictable and major impact on neurodevelopment (e.g., Trisomy 21, DiGeorge syndrome). 6. Pregnant individual is aged <18 years. 7. Pregnant individual is carrying a surrogate pregnancy. 8. Consented mother completes <70% of survey questions at first (baseline) assessment.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
Participants will be randomized 1:1 to the HeartGPS mental health intervention or standard of care.
Primary Purpose
Supportive Care
Masking
Double (Care Provider, Investigator)

Arm Groups

ArmDescriptionAssigned Intervention
No Intervention
Usual Fetal Cardiac Care
This is standard of care.
Experimental
HeartGPS
Usual Fetal Cardiac Care + HeartGPS intervention. GPS stands for Guiding parents through emotions, Providing information and support, and Strengthening connections. The HeartGPS intervention includes three key components tailored to the CHD population: 1. Eight virtually administered counseling sessions, 2. Tailored educational resource, 3. Mental health care plan.
  • Other: HeartGPS
    GPS stands for Guiding parents through emotions, Providing information and support, and Strengthening connections. Participants randomized to the treatment group will participate in HeartGPS, which includes three key components tailored to the CHD population: 1. Eight virtually administered counseling sessions, 2. Tailored educational resource, 3. Mental health care plan.

Recruiting Locations

Children's Healthcare of Atlanta
Atlanta, Georgia 30322
Contact:
Principal Investigator

University of Michigan Health System, Ann Arbor
Ann Arbor, Michigan 48109
Contact:
Principal Investigator

Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
Contact:
Principal Investigator

Medical University of South Carolina
Charleston, South Carolina 29425
Contact:
Principal Investigator

Le Bonheur Children's Hospital
Memphis, Tennessee 38103
Contact:
Principal Investigator

More Details

Status
Recruiting
Sponsor
Carelon Research

Study Contact

Stephanie Lynch, MPH
339-368-9294
stephanie.lynch@carelon.com

Detailed Description

This is a domain of the Building Optimal Strategies to Enhance Parent and Infant Wellbeing in CHD (BOND) platform trail. BOND is a randomized, multifactorial, adaptive platform trial that seeks to optimize parent wellbeing and infant development following prenatal or neonatal diagnosis of congenital heart disease (CHD). The primary objective of this domain is to determine the effects of a prenatally initiated, virtually administered mental health intervention, called HeartGPS, on maternal mental health and infant development following prenatal CHD diagnosis.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.